Acute Pain

Dr. Califf formerly led the FDA during the Obama Administration.

The randomized control trial investigates the effectiveness of cognitive behavioral therapy in treating chronic pain in patients who have been using opioid therapy.

New study finds that patients with neuropathic pain may benefit from cannabis-based medicine or medical cannabis.

The agent is administered through a single-dose, pre-filled syringe that delivers 5 milligrams through intramuscular or subcutaneous injection.

Dr. Simona Bujoreanu explains the importance of acknowledging the psychological aspect of chronic pain management.

Dr. Simona Bujoreanu discusses the different types of barriers that are faced when treating chronic pain in pediatric patients.

Dr. Bujoreanu explains how treatments like Cognitive Behavioral Therapy can have a positive impact on chronic pain in pediatric patients.

Tramadol is examined alongside codeine to determine if it puts patients at a higher risk of adverse cardiovascular events.

Clinicians identified key strategies that could improve the challenge of treating lower back pain in emergency departments.

Results show an increase in methamphetamine use, methamphetamine use disorder, and overdose mortality.

Patients with chronic pain may benefit from rotation to buprenorphine.

Patients with lower pain intensity were more accepting of telemedicine treatments.

Study shows single-session pain relief class noninferior to 8-session cognitive behavioral therapy for pain catastrophizing, pain intensity, and pain interference.

In part 2 of an interview with HCPLive, Dr. Saxe focuses on the role of microbiota in pain and how concomitant conditions in patients are often nutritionally linked.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

Dr. Marienfield discusses stigma as a major barrier in addiction treatment, as well as determining success based on patient goal.

Dr. Marienfield discusses therapy options for substance abuse patients in recovery.

Opioids are likely still needed in most cases following trauma or surgery.

Data show patients expected moderate improvements across all PCOQ domains with a median improvement range of 45% - 53.7%.

Dr. Moeller-Bertram will co-chair a live conference focusing on the different aspects of treating pain.

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

Data show prevalence of pain increased with age in all age groups, while it was lower among men and non-Hispanic Asian adults.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

A new study finds a 2-step chronic pain screening process helped identify patients in primary care with previously undocumented chronic pain.